Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Finasteride is a medicine used to treat enlarged prostate and prostate cancer, and it works by changing how testosterone works in the body.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

GI197111X is best dissolved in Capmul MCM for trials.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tangent screens help detect visual field defects from vigabatrin.

Cancer prevention has advanced significantly, with some strategies proving successful.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Epidermal growth factor helps hair recover after chemotherapy.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.